Anne Corwin is an engineer and technoprogressive activist based in California. She is an intern with the Institute for Ethics and Emerging Technologies and a volunteer for the Methuselah Foundation. She is also the author of the blog Existence is Wonderful and produces the associated podcast, Existence is Wonderful audio. In this talk with Accelerating Future’s founder Michael Anissimov, she spoke on how futurist topics like neurodiversity, life extension and self-modification are relevant to discussion today.
Cryonics researchers Chana de Wolf and Aschwin de Wolf
Moderated by Aschwin de Wolf, the critical care medical panel of the 7th Alcor Conference addressed the current status on laws that affect the practice of cryonics, the ethical debate concerning non heart-beating organ donation (NHBD), and comparisons between organ procurement procedures and cryonics. Questions were fielded by participants Tanya Jones (Alcor’s Chief Operating Officer), David Crippin (Associate Professor of Critical Care Medicine at the University of Pittsburgh Medical center) and Leslie Whetstine (Ph.D. in Health Care Ethics).
Alcor Chief Administrative Officer Jennifer Chapman and Chief Operating Officer Tanya Jones
Tanya Jones has participated in the cryopreservation of over half of Alcor’s 78 cryopreserved patients. She started her career at the life extension organization over a decade ago and her experience as the Chief Operating Officer is effectuating innovative change within the organization. As the leader of Alcor’s emergency response capability, she is actively responsible for elevating the level of care. She shared details of present-day initiatives to provide the state-of-the art in cryonics technology at the 7th Alcor Conference.
Aubrey de Grey is a biomedical gerontologist seeking a cure for human aging. He has recently published a book on the topic entitled Ending Aging: The Rejuvenation Breakthroughs That Could Reverse Human Aging in Our Lifetime. He is open and supportive of his arrangements to be cryopreserved with Alcor Life Extension, and at the 7th Alcor Conference in Scottsdale, Arizona he discussed his decision to make it known in a presentation entitled “Is It Safe for a Biologist to Support Cryonics Publicly?”
Bruce Klein, Tanya Jones, and Aubrey de Grey at the 6th Alcor Conference in Scottsdale, Arizona
Tanya Jones, Alcor’s Chief Operating Officer, has been actively involved with the organization since 1990. She has devoted a decade of work to cryonics overseeing the cryopreservation process, improving procedures, and managing Alcor’s day-to-day operations. She held the titles of Program Architect and Director of Communication at the Foresight Nanotech Institute and has participated in the cryopreservation procedures of half of Alcor’s patient population. At the 6th Alcor Conference she gave a talk on the efforts to provide and protect the wealth preservation trusts necessary to support and eventually revive cryopreserved patients.
Brian Wowk presenting at the 6th Alcor Conference in Scottsdale
Brian Wowk is a Senior Scientist at 21st Century Medicine, Inc. where he studies the low temperature preservation of tissues and organs for medical use. He was a co-founder with Dr. Gregory Fahy of technology permitting successful cryonic temperature preservation of the mammalian kidney. Cryobiology studies show steady progress in the quality with which brain information can be preserved under ideal conditions. However the absence of demonstrable reversibility, and the vast variety of conditions under which cryopreservations can take place, introduce uncertainty in the “information theoretic” paradigm of cryonics. At the 6th Alcor Conference in Scottsdale, Arizona, Dr. Wowk gave a talk on the basis of cryonics in the science of cryobiology, while deconstructing several popular myths of cryobology.
Aubrey de Grey presenting at the 6th Alcor Conference in Scottsdale
Aubrey de Grey is the editor of Rejuvenation Research, the world’s only peer-reviewed journal focused on intervention in aging, he is an advocate of research seeking answers to how molecular and cellular metabolic damage brings about aging and ways humans can intervene to repair and/or obviate that damage. At the 2006 Alcor conference in Scottsdale, Arizona, he gave a presentation on how implementing Strategies for Engineered Negligible Senescence might be viewed as a precursor to the prospect of reviving patients from cryonic suspension.
Ralph Merkle and Tanya Jones answering questions from the audience at Transvision 2007
Ralph Merkle co-invented public key cryptography, for which he received the ACM Kanellakis Award, the IEEE Kobayashi Award, and the 2000 RSA Award in Mathematics. He is directly involved in the research of molecular manufacturing, also called nanotechnology or molecular nanotechnology. The central objective of which is the design, modeling, and manufacture of systems that can inexpensively fabricate most products that can be specified in molecular detail. Such systems are today theoretical, but should revolutionize 21st century manufacturing.
Dr. Merkle is a distinguished professor at the College of Computing at Georgia Institute of Technology and previous nanotechnology researcher and theorist at Xerox Palo Alto Research Center and Zyvex corporations. He has served for several years as an executive editor of the journal Nanotechnology, chaired both the Fourth and Fifth Foresight Conferences on Molecular Nanotechnology, and won the 1998 Feynman Prize in Nanotechnology for theory. At the 6th Alcor conference in Scottsdale, Arizona he delivered a talk entitled “Nanotechnology and Cryonics,” outlining the intersection between the two developing fields of science.